论文信息 - Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer - 字舞流文

Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer

C. Pirker | W. Berger | W. Jäger | M. Grusch | P. Heffeter | S. van Schoonhoven | A. Terenzi | B. Englinger | G. Timelthaler | C. Kowol | Daniela Heilos | J. Senkiv | Patrick Moser | L. Gabler | S. Kallus | Lisa Gabler | Sebastian Kallus | Alessio Terenzi | B. Englinger